Sodium channel blockers and axonal protection in neuroinflammatory disease.
Waxman
Stephen G
SG
Department of Neurology and The Center for Neuroscience and Regeneration Research, Yale Medical School, 333 Cedar Street, PO Box 208018, New Haven, CT 06520-8018, USA. Stephen.Waxman@yale.edu
D001369:Axons / Q000187:drug effects* / Q000502:physiology; D003711:Demyelinating Diseases / Q000503:physiopathology*; D004679:Encephalomyelitis / Q000503:physiopathology; D020275:Guillain-Barre Syndrome / Q000503:physiopathology; D006801:Humans; D009103:Multiple Sclerosis / Q000503:physiopathology; D009410:Nerve Degeneration / Q000503:physiopathology; D010100:Oxygen / Q000502:physiology; D026941:Sodium Channel Blockers / Q000494:pharmacology*
D026941:Sodium Channel Blockers; D010100:Oxygen